Lv4
565 积分 2021-08-12 加入
From TCR fundamental research to innovative chimeric antigen receptor design
3天前
已完结
Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models
5天前
已完结
The ouroboros of autoimmunity
5天前
已完结
CAR macrophages on a fast track to solid tumor therapy
2个月前
已完结
CAR macrophages tuning the immune symphony of anti-cancer therapies
2个月前
已完结
CAR macrophages tuning the immune symphony of anti-cancer therapies
3个月前
已完结
Programmable Bacteria‐Based Biohybrids as Living Biotherapeutics for Enhanced Cancer Sonodynamic‐Immunotherapy
4个月前
已完结
The peritumor microenvironment: physics and immunity
5个月前
已完结
Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1
5个月前
已完结
LOXL2 in pancreatic tumourigenesis: the complexity of tumour–stromal crosstalk exemplified
5个月前
已完结
皖公网安备34019202002308
